iRhythm Technologies Inc. (IRTC) stock plummeted 5.93% during intraday trading on Friday, as the market reacted to a series of downward revisions in analyst price targets for the company.
The sell-off appears to be driven by negative analyst actions, with several major investment firms significantly lowering their price targets for iRhythm. JPMorgan cut its target to $175 from $215, Oppenheimer reduced its target to $185 from $225, and Evercore ISI lowered its target to $160 from $170.
These downward revisions by multiple analysts suggest growing concerns about the company's future prospects, prompting investors to adjust their positions during the trading session.